ContextLogic Inc. (LOGC): A Bull Case Theory
We came across a bullish thesis on ContextLogic Inc. (LOGC) on Substack by Polymath Investor. In this article, we will summarize the bulls’ thesis on LOGC. ContextLogic Inc.
Contextlogic Holdings Inc. (LOGC)
Market is closed
Sector: Consumer Cyclical
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.76 | 10,000 | $97,600.00 | 60,000 | 2026-06-12 | Filing | |
| $9.17 | 12,926 | $118,548.22 | 638,112 | 2026-06-08 | Filing | |
| $9.06 | 63,019 | $571,210.52 | 625,186 | 2026-06-05 | Filing | |
| $9.04 | 1,000 | $9,040.00 | 562,167 | 2026-06-04 | Filing | |
| $9.02 | 35,409 | $319,367.93 | 561,167 | 2026-06-03 | Filing |
News See All
ContextLogic Inc. (LOGC): A Bull Case Theory
We came across a bullish thesis on ContextLogic Inc. (LOGC) on Substack by TripleS Special Situations. In this article, we will summarize the bulls’ thesis on LOGC. ContextLogic Inc.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
In this article we will analyze whether LogicBio Therapeutics, Inc.
Is LogicBio Therapeutics, Inc. (LOGC) Going to Burn These Hedge Funds?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Cutting Exposure To LogicBio Therapeutics, Inc. (LOGC)
In this article we will take a look at whether hedge funds think LogicBio Therapeutics, Inc. (NASDAQ:LOGC) is a good investment right now.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Fund Resource Center